
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
The provided excerpts indicate a positive outlook for UnitedHealth Group, driven by a projected growth in Medicare Advantage (MA) enrollment, expected to increase by approximately 800,000 members year-over-year, translating to a 10% rise in overall enrollment. Additionally, the company's focus on HMO growth, which is seen as more manageable in terms of costs compared to PPO, further supports its robust growth strategy in the evolving healthcare market. Furthermore, management anticipates an acceleration in earnings per share (EPS) growth towards the range of 13-16% by 2026, alongside an improved margin profile for its OptumInsight segment, which is expected to enhance overall financial performance.
Bears say
UnitedHealth Group has experienced a sequential decline in Optum Health consumers, dropping to 100 million from 104 million in the third quarter, which raises concerns about membership retention and growth potential. The fourth-quarter earnings per share of $6.81, although above street estimates, highlighted a managed care ratio (MLR) miss at 87.6%, driven primarily by lower revenue linked to Medicare Advantage group refunds and increased seasonal costs from flu and RSV. Additionally, the company faces significant investment risks, including regulatory pressures related to Medicare and Medicaid, ineffective pricing strategies, and rising utilization of medical services, all of which could adversely impact financial performance and outlook.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares